Scarica l'app Stockscreener
228.44
0.45%
-1.04
Dopo l'orario di chiusura:
228.75
0.31
+0.14%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABBV Giù?
Forum
Previsione
Storia dei dividendi
Abbvie Inc Borsa (ABBV) Ultime notizie
RBC Capital initiates Abbvie stock coverage with outperform rating - Investing.com
AbbVie Tests Exclusion Strategy In Drug Price Fight - Law360
How Pipeline Shifts And Competition Are Reshaping The AbbVie (ABBV) Investment Narrative - Yahoo Finance
AbbVie makes $380 million ‘made in the U.S.’ move - thestreet.com
Governor Pritzker Announces Major AbbVie Manufacturing Expansion - RiverBender.com
AbbVie to spend $380M on two new manufacturing facilities in Illinois - Manufacturing Dive
Is AbbVie Stock Underperforming the Dow? - Yahoo Finance
AbbVie Plans to Launch Offering of Senior Notes - marketscreener.com
AbbVie to Present at the TD Cowen 46th Annual Health Care Conference - Investing News Network
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
This High‑Yield Pharma Beast AbbVie Could Turn Dividends Into Life‑Changing Income - Yahoo Finance
AbbVie announces $380m investment in North Chicago API facilities - Pharmaceutical Technology
FDA Approves AbbVie (ABBV) VENCLEXTA and Acalabrutinib Combination for First-Line CLL - Yahoo! Finance Canada
North Chicago-based AbbVie investing $380 million on new pharmaceutical plants - Chicago Sun-Times
AbbVie (ABBV) to Invest $380M in New Pharmaceutical Plants - GuruFocus
AbbVie to invest $380 million to expand US manufacturing in Illinois - 1470 & 100.3 WMBD
AbbVie reveals blueprints for two new manufacturing sites in Chicago - FirstWord Pharma
AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States - Investing News Network
AbbVie to build 2 more manufacturing facilities in North Chicago with $380M investment - The Business Journals
AbbVie plans to spend $380 million building two new manufacuturing facilities in North Chicago - Yahoo Finance
'Forefront of innovation': State announces major $380M expansion at AbbVie in Lake County, creating 300 new jobs - Lake and McHenry County Scanner
Barclays Initiates AbbVie (ABBV) with Overweight Rating on Growth Potential - Finviz
AbbVie plans $380 million manufacturing expansion in North Chicago - StreetInsider
AbbVie to build 2 new manufacturing facilities at North Chicago headquarters, company and Gov. Pritzker announce - WGN-TV
AbbVie plans $380M manufacturing expansion in Illinois - Investing.com
AbbVie (ABBV) Invests $380M in New Manufacturing Facilities - GuruFocus
AbbVie to Invest $380 Million in Chicago to Further Expand US API Manufacturing - CHEManager
AbbVie to Invest $380 Million in 2 New Facilities in Illinois - marketscreener.com
AbbVie to Invest $380 Million to Construct 2 Active Pharmaceutical Ingredient Production Sites in Chicago - marketscreener.com
AbbVie to invest $380M in two API manufacturing facilities at Illinois campus - TipRanks
AbbVie announces $380 million investments in North Chicago - marketscreener.com
Abbvie Announces $380 Million Investments In North Chicago - TradingView
AbbVie investing $380M on two new plants in North Chicago, adding 300 employees - Crain's Chicago Business
AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States – Company AnnouncementFT.com - Financial Times
Students - AbbVie
UK's NICE Recommends AbbVie's Follicular Lymphoma Drug - marketscreener.com
Johnson & Johnson vs. AbbVie: A Growth Showdown Amid Patent Cliffs - The Globe and Mail
Theodora Ross Joins Ideaya, Leaving Impact on AbbVie (ABBV) - GuruFocus
AbbVie Expands IPF Pipeline With New Phase 2a Study of ABBV-142 - The Globe and Mail
Heartland Bank & Trust Co Has $3.85 Million Position in AbbVie Inc. $ABBV - MarketBeat
Siligmueller & Norvid Wealth Advisors LLC Purchases Shares of 12,436 AbbVie Inc. $ABBV - MarketBeat
AbbVie (NYSE:ABBV) Upgraded to Strong-Buy at Barclays - MarketBeat
Fiera Capital Corp Has $38.12 Million Stake in AbbVie Inc. $ABBV - MarketBeat
New Graduates & Entry-Level positions - AbbVie
ABBV Stock Quote Price and Forecast - CNN
Beyond the Balance Sheet: What SWOT Reveals About AbbVie Inc (AB - GuruFocus
Evercore notes AbbVie Inc.’s (ABBV) Tremfya gains market share, but future earnings growth may be limited - MSN
Students & New Graduates - AbbVie
AbbVie Inc. SEC 10-K Report - TradingView
AbbVie wins FDA nod for leukemia therapy (update) (ABBV:NYSE) - Seeking Alpha
Woodley Farra Manion Portfolio Management Inc. Buys 11,527 Shares of AbbVie Inc. $ABBV - MarketBeat
Barclays Initiates Coverage on ABBV with Overweight Rating | ABB - GuruFocus
Barclays Initiates Coverage of AbbVie (ABBV) with Overweight Recommendation - Nasdaq
Dividend Roundup: Halliburton, AbbVie, Johnson & Johnson, Delta Air Lines, and more - Seeking Alpha
Will Immunology Drugs Continue to Drive AbbVie's Top Line in 2026? - TradingView
FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer - Benzinga
Barclays initiates Abbvie stock with overweight on leverage potential - Investing.com
FDA Approves AbbVie's (ABBV) New CLL Treatment Regimen - GuruFocus
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Increases Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
US regulator FDA greenlights AbbVie and AstraZeneca's cancer treatment - marketscreener.com
FDA Approves AbbVie's (ABBV) New Treatment Combo for Leukemia - GuruFocus
AbbVie Says FDA Approves Cancer Combo Therapy - marketscreener.com
FDA approves first all-oral, fixed-duration option for CLL - Stock Titan
AbbVie (NYSE:ABBV) At Midday As Traders Watch Nyse Composite Closely - Kalkine Media
AbbVie Inc. (NYSE:ABBV) Declares Quarterly Dividend of $1.73 - MarketBeat
0.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):